Snapshot from Aug 23, 2026 at 07:00 UTC. For live data and tracking: View Live
Business insider buying

Cerrone increases Tiziana stake

Analysis based on 14 articles · First reported Jul 22, 2026 · Last updated Jul 22, 2026

Sentiment
20
Attention
1
Articles
14
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The insider purchase signals confidence from the chairman, potentially boosting investor sentiment. However, the small size of the purchase relative to total shares may limit market impact.

biotechnology

On July 22, 2026, Tiziana Life Sciences announced that its Executive Chairman and Founder, Gabriele Cerrone, through Panetta Partners Limited, purchased 42,357 common shares at $0.99 per share, increasing his total holdings to 44,814,587 shares, representing 34.93% of issued share capital. Tiziana is a clinical-stage biopharmaceutical company developing intranasal foralumab, a fully human anti-CD3 monoclonal antibody, for neuroinflammatory and neurodegenerative diseases. The company has ongoing clinical trials for non-active secondary progressive multiple sclerosis.

stock
Tiziana Life Sciences is the company whose shares were purchased by its chairman, signaling insider confidence.
Importance 100.0 Sentiment 20.0
per
Gabriele Cerrone, Executive Chairman and Founder, increased his stake in Tiziana, demonstrating commitment to the company.
Importance 80.0 Sentiment 20.0
priv
Panetta Partners Limited is the entity through which Cerrone made the share purchase, acting as a vehicle for his investment.
Importance 30.0 Sentiment 10.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.